How well do you know your bones? Q: At birth the human body has around 270 soft bones, but how many do we have as an adult, is it more or less? Check back later to find out #WisdomWednesday #biotech #TissueRegenix

A: Once the human body reaches adulthood it is made up of 206 bones. Click the article below from Medical News Today to find out all you need to know about bones. medicalnewstoday.com/articles/32044… #WisdomWednesday #biotech #tissueregenix

We understand how devastating ligament injuries can be for teams like our local Leeds United following the injury sustained by Kemar Roofe. That's why we are working hard developing our innovative ligament reconstruction technology #sport #injury #biotech #regenerativemedicine #Leeds

Our people are our biggest asset and we are always looking for talented individuals to join our team. Check out our LinkedIn page for vacancy updates 👩‍🔬👨‍🔬 linkedin.com/company/665141… #vacancies #graduation

Today's Question: How many ACL reconstructions do you think take place each year around the world? 🤔 Check back later to find out #WednesdayWisdom

Answer: There are estimated to be an incredible 1.5 million ACL reconstructions taking place each year worldwide! Take a look at our website to find out more - tissueregenix.com/products/ortho… #WednesdayWisdom #Orthopedics

He scored an incredible goal for Man City at the weekend, but Gundogan's journey back to football after a devastating ACL injury was not an easy one. Read the full story here: nytimes.com/2017/09/20/spo… #ManCity #football

You read about his incredible ACL recover yesterday, but can Gundogan make the difference this weekend for Manchester City against a tough Watford Football Club team in the Emirates FA Cup final? What do you think? 🤔⚽️#FACupFinal #football

We are delighted to announce that, after undergoing medical treatment the first part of this year, our CEO, Steve Couldwell will be returning to full-time duties in June. Welcome back Steve! #TissueRegenix #WelcomeBack proactiveinvestors.co.uk/news/details/2…

We are delighted to announce we have secured $20m funding from MidCap Financial, allowing us to continue our business growth and development well into the future. Read the full announcement here: polaris.brighterir.com/public/tissue_…

🚀NEW WEBSITE LAUNCH 🚀 We are delighted to announce the launch of our new website. Come and take a look around tissueregenix.com Jones and Palmer

Regenerative Medicine's Promise to Patients Our very own President of TRX BioSurgery, Joel Pickering explains how technology can prevent ongoing tissue damage and degeneration #biotech #TuesdayThoughts #Science medtechintelligence.com/column/regener…

If you liked Joel's article "Regenerative Medicine's Promise to Patients" (find the article link in our profile) why not learn more about our work in the BioSurgery sector on our new website. Click the link to discover more: tissueregenix.com/biosurgery/ove… … #biotech #science #discover

"Credit facilities expand cash runway to 2021" The Tissue Regenix Hardman & Co research note for full year 2018 has now been published. Click the link below to read more: tissueregenix.com/media/2232/har…

"I am delighted that we have secured this additional facility to support our ambitious growth plans" Tissue Regenix expands manufacturing facilities in the US to meet the growing commercial demand tissueregenix.com/investors/rns/

We are excited to be here at the #nass2019 meeting! Stop by booth 4608 to learn more about our CellRight Technologies osteoinductive product portfolio

Our 2019 trading update has been released! Revenue anticipated to be £13m, representing an annual increase of 12%. Learn more here: tissueregenix.com/investors/rns/

Following the cyber security incident last week, we are delighted to confirm that the recovery has now been completed and all critical IT systems have been restored and brought back online. Processing in the Company's United States facility has also resumed with immediate effect.

Update in relation to working capital position - cost control measures successfully implemented resulting in the Board's belief that the available cash runway will now continue to support the business until at least the end of the second week of May 2020 tissueregenix.com/investors/rns/